Skip to main content
. 2015 Mar 30;2(2):ENEURO.0009-15.2015. doi: 10.1523/ENEURO.0009-15.2015

Figure 6.

Figure 6

Combined infusion of AP-5/SCH23390 significantly impaired behavioral activity when administered immediately prior to the VR5 reactivation. A, Coinfusion of AP-5/SCH23390 (n = 6) significantly impaired lever pressing at test compared with PBS controls (n = 6). Infusions of MK-801 (n = 6), AP-5 (n = 5), or SCH23390 (n = 6) alone were without significant long-term effect on lever pressing. B, There was no significant evidence for any long-term impairment in nosepoking with any infusion. Data are represented as mean + SEM.